DEFEYE
Live / Allowed — Publication / registration review complete (as of 18 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99287836
- Mark type
- Stylized text
- Filed
- 16 Jul 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Garth Coviello
Goods and services
- Class 005 — Pharmaceuticals: Amniotic membrane single and multiple layer allografts to be used as a biological membrane for use in providing the extracellular matrix and repairing damaged tissue including damage resulting from ocular surface disease, corneal and conjunctival-related injuries or defects such as corneal epithelial defects, pterygium repair, fornix reconstruction, and other ocular procedures; Medical diagnostic preparations, reagents, and assays for detecting analytes in tear fluid
Owner
- DEFEYE, Inc., Sarasota, FL, US
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2025 — NON-FINAL ACTION E-MAILED
- 12 Dec 2025 — NON-FINAL ACTION WRITTEN
- 04 Dec 2025 — ASSIGNED TO EXAMINER
- 16 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 16 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 16 Jul 2025 — NEW APPLICATION ENTERED